２０２３年

2023年 業績

  1. Harada K, Ohyama M, Niiyama S, Irisawa R, Mae K, Mori M, Wakimoto H, Kinoshita-Ise M, Fukuyama M, Hayakawa R, Takagi M, Yamazaki M, Miyoshi M, Nishikawa S, Sato S, Nakazawa Y, Sugimoto T, Ogo M, Tsuboi R: Efficacy of autologous dermal sheath cup cell transplantation in male and female pattern hair loss: A Single-Arm, Multi-Center, phase III equivalent clinical study. J Dermatol 50(12): 1539-1549, 2023.12
  2. Hordinsky M, Hebert AA, Gooderham M, Kwon O, Murashkin N, Fang H, Harada K: Law E, Wajsbrot D, Takiya L, Zwillich SH, Wolk R, Tran H. Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial. Pediatr Dermatol 40(6): 1003-1009, 2023.11.
  3. Morita A, Tsai TF, Yee EYW, Okubo Y, Imafuku S, Zheng M, Li L, Quaresma M, Thoma C, Choon SE: Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study. J Dermatol 50(2): 183-194, 2023.02
  4. Saeki H, Mabuchi T, Asahina A, Abe M, Igarashi A, Imafuku S, Okubo Y, Komine M, Sano S, Torii H, Morita A, Yotsuyanagi H, Watanabe A, Ohtsuki M, Committee for reviewing the safety of molecularly targeted drugs for psoriasis, Japanese Dermatological Association: English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). J Dermatol 50(2): e41-e68, 2023.02
  5. Yamanaka K, Okubo Y, Yasuda I, Saito N, Messina I, Morita A: Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. J Dermatol 50(2): 195-202, 2023.02
  6. Morita A, Tsai TF, Yee EYW, Okubo Y, Imafuku S, Zheng M, Li L, Quaresma M, Thoma C, Choon SE: Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled EffisayilTM 1 study. J Dermatol 50(2): 183-194, 2023.02
  7. Asahina A, Okubo Y, Morita A, Tada Y, Igarashi A, Langley RG, Deherder D, Matano M, Vanvoorden V, Wang M, Ohtsuki M, Nakagawa H. Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatol Ther (Heidelb) 13(3): 751-768, 2023.03
  8. Takimoto-Ito R, Kambe N, Kogame T, Nomura T, Izawa K, Jo T, Kazuma Y, Yoshifuji H, Tabuchi Y, Abe H, Yamamoto M, Nakajima K, Tomita O, Yagi Y, Katagiri K, Matsuzaka Y, Takeuchi Y, Hatanaka M, Kanekura T, Takeuchi S, Kadono T, Fujita Y, Migita K, Fujino T, Akagi T, Mukai T, Nagano T, Kawano M, Kimura H, Okubo Y, Morita A, Hide M, Satoh T, Asahina A, Kanazawa N, Kabashima K: Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan. Allergol Int 72(2):297-305, 2023 .04
  9. Morita A, Okubo Y, Imafuku S, Tada Y, Yamanaka K, Sugiura K, Yamaguchi Y, Yasuda M, Tsuchihashi H, Saitoh M, Sakamoto W, Okuyama R: Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review study. JEADV Clin Pract : 261–272, 2023
  10. Saeki H, Mabuchi T, Asahina A, Abe M, Igarashi A, Imafuku S, Okubo Y, Komine M, Takahashi K, Torii H, Morita A, Yotsuyanagi H, Watanabe A, Ohtsuki M: Committee for reviewing the safety of molecularly targeted drugs for psoriasis, Japanese Dermatological Association. English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. J Dermatol 50(5): e138-e150, 2023.05
  11. Burden AD, Okubo Y, Zheng M, Thaçi D, van de Kerkhof P, Hu N, Quaresma M, Thoma C, Choon SE: Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study. Exp Dermatol 32(8): 1279-1283, 2023.05
  12. Tada Y, Morita A, Yamanaka K, Kono M, Imafuku S, Okubo Y, Yamazaki F, Kawamura T, Itakura A, Ohtsuki M. Real-world retention rates and effectiveness of secukinumab in psoriasis: Results from a multicenter cohort study (RAILWAY). J Dermatol 50(11): 1415-1426, 2023.
  13. Kurokawa I, Nomura Y, Nogita T: A tentative new terminology: initial comedonal phase preceeding acute inflammatory phase of acne vulgaris-importance of early treatment. J Costmet Dermatol Sci and Application 13: 179-181, 2023
  14. Nojo H, Hiruma J, Noguchi H, Hiruma M, Harada K, Makimura K, Kano R: In vitro Azole Susceptibility Testing of Japanese Isolates of Itraconazole-Resistant Dermatophytes. Med Mycol J 64(4):103-105, 2023.06
  15. Hiruma J, Noguchi H, Shimizu T, Hiruma M, Harada K, Kano R. Epidemiological study of antifungal-resistant dermatophytes isolated from Japanese patients. J Dermatol 50(8):1068-1071, 2023.08
  16. Hiruma J, Nojo H, Tsuchihashi H, Noguchi H, Hiruma M, Harada K, Kano R: Internal Transcribed Spacer Region Typing of Trichophyton interdigitale Isolated from Japanese Patients. Mycopathologia 188(4): 395-399, 2023.08.
  17. Hiruma J, Kimura U, Noguchi H, Hiruma M, Harada K, Kano R: In vitro Azole Susceptibility Testing of Japanese Isolates of Terbinafine-Resistant Trichophyton indotineae and Trichophyton rubrum. Med Mycol J 64(1): 23-25, 2023.10.
  18. Fujimori K, Kato Y, Umebayashi Y: Resolution of palmoplantar pustulosis and associated osteoarthritis after colorectal cancer surgery. Int J Dermatol 62(5): e279-e281, 2023.05
  19. Suzuki R, Numata T, Hiruma J, Maeda T, Tsuboi R, Harada K. Wolf's isotopic response after tinea corporis caused by Microsporum canis. J Dermatol 50(5):e159-e161, 2023.05.
  20. Nishi W, Wakamatsu E, Machiyama H, Matsushima R, Saito K, Yoshida Y, Nishikawa T, Takehara T, Toyota H, Furuhata M, Nishijima H, Takeuchi A, Azuma M, Suzuki M, Yokosuka T: Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclusters. Nat Commun 14(1):3157, 2023.01
  21. Seshimo H, Egusa C, Maeda T, Numata T, Okubo Y, Harada K, Ito T: Topical application of imatinib mesylate suppresses vitamin D3 analog-induced dermatitis in Balb/c mice. Exp Dermatol 32(4): 413-424, 2023.04
  22. Hayakawa K, Maeda T, Egusa C, Okubo Y, Harada K: Topical application of imatinib mesylate ameliorated psoriasis-like skin lesions in imiquimod-induced murine model via angiogenesis inhibition. Exp Dermatol 32(6): 878-888, 2023.06
  23. 川村飛翔, 坪井良治, 蒲原毅: 禿髪性毛包炎. 皮病診療 45(7): 610-613, 2023.07
  24. 原田和俊, 橋本貴, 深山浩: インターネットアンケートによる皮膚科医を対象とした爪白癬の薬物治療実態調査. 日臨皮医誌 40(1): 44-53, 2023.01
  25. 山本亜紀, 神部芳則, 柏崎明子, 森良之, 野口忠秀, 小宮根真弓, 出光俊郎: 家族性および非家族性白色海綿状母斑の細胞接着構造に関する電子顕微鏡的検討. 日口内誌 29(1): 1-6, 2023.06
  26. 伊藤友章, 沼田貴史, 小林知子, 城理沙, 瀬下治孝, 原田和俊, 大久保ゆかり: 東京医科大学病院皮膚科でデュピルマブによる治療を行ったアトピー性皮膚炎患者201例の統計. アレルギー 72(3): 281-287, 2023.05
  27. 神﨑美玲: 実践ケーススタディ よく遭遇する皮膚の困りゴト 全身が痒い 強いかゆみを伴う発疹. medicina 60(12): 2073-2076, 2023.11
  28. 小林知子, 伊藤友章, 瀬下治孝, 江草智津, 原田和俊, 大久保ゆかり, 新妻知行: 緑豆もやしによるアレルギーの2例. アレルギー 72(8): 1046-1050, 2023.09

皮膚科学分野について

皮膚科診療について

研究・業績